Follow
Andrea Pensado
Andrea Pensado
Verified email at oist.jp
Title
Cited by
Cited by
Year
Current strategies for DNA therapy based on lipid nanocarriers
A Pensado, B Seijo, A Sanchez
Expert Opinion on Drug Delivery 11 (11), 1721-1731, 2014
672014
Topical bioavailability of diclofenac from locally-acting, dermatological formulations
SF Cordery, A Pensado, WS Chiu, MZ Shehab, AL Bunge, ...
International journal of pharmaceutics 529 (1-2), 55-64, 2017
532017
Development and characterisation of chondroitin sulfate-and hyaluronic acid-incorporated sorbitan ester nanoparticles as gene delivery systems
I Fernandez-Piñeiro, A Pensado, I Badiola, A Sanchez
European Journal of Pharmaceutics and Biopharmaceutics 125, 85-94, 2018
332018
Stratum corneum sampling to assess bioequivalence between topical acyclovir products
A Pensado, WS Chiu, SF Cordery, E Rantou, AL Bunge, ...
Pharmaceutical research 36, 1-16, 2019
302019
Span poly-L-arginine nanoparticles are efficient non-viral vectors for PRPF31 gene delivery: An approach of gene therapy to treat retinitis pigmentosa
A Pensado, FJ Diaz-Corrales, B De la Cerda, L Valdes-Sanchez, ...
Nanomedicine: Nanotechnology, Biology and Medicine 12 (8), 2251-2260, 2016
222016
Characterization and comparison of two novel nanosystems associated with siRNA for cellular therapy
EM Andre, A Pensado, P Resnier, L Braz, AMR da Costa, C Passirani, ...
International journal of pharmaceutics 497 (1-2), 255-267, 2016
212016
Anionic nanoparticles based on Span 80 as low-cost, simple and efficient non-viral gene-transfection systems
A Pensado, I Fernandez-Piñeiro, B Seijo, A Sanchez
International Journal of Pharmaceutics 476 (1-2), 23-30, 2014
212014
Skin pharmacokinetics of transdermal scopolamine: measurements and modeling
A Pensado, L Hattam, KAJ White, A McGrogan, AL Bunge, RH Guy, ...
Molecular Pharmaceutics 18 (7), 2714-2723, 2021
112021
Nanoparticulate systems prepared from Sorbitan esters
A Sanchez, B Seijo, GK Zorzi, E Calvalho, A Pensado
WO2013068625 A1 16, 2013
92013
Structural analysis of nanosystems: Solid Sorbitan esters Nanoparticles (SSN) as a case study
A Pensado, M Martin-Pastor, GK Zorzi, ES Carvalho, A Sanchez
European Journal of Pharmaceutics and Biopharmaceutics 104, 189-199, 2016
62016
Assessment of dermal bioavailability: predicting the input function for topical glucocorticoids using stratum corneum sampling
A Pensado, A McGrogan, KAJ White, AL Bunge, RH Guy, ...
Drug Delivery and Translational Research, 1-11, 2022
32022
Nanoparticulate systems prepared from sorbitan esters
AS Barreiro, BS Rey, GK Zorzi, ELS CARVALHO, AP Lopez
US Patent 9,861,588, 2018
32018
Solid sorbitan esters nanoparticles are efficient and low-cost vehicles for subunit vaccines: Proof of concept with Neisseria meningitidis protein Mip
P Freixeiro, A Pensado, L Allen, H Humphries, S Taylor, B Seijo, ...
Journal of Drug Delivery Science and Technology 42, 299-306, 2017
32017
Correction to “Skin Pharmacokinetics of Transdermal Scopolamine: Measurements and Modeling”
A Pensado, L Hattam, KAJ White, A McGrogan, AL Bunge, RH Guy, ...
Molecular Pharmaceutics 19 (7), 2681-2682, 2022
2022
Nanoparticulate systems for use in gene transfer or gene delivery
FJ Díaz-Corrales, SS Bhattacharya, B Cerda, ML Valdés-Sánchez, ...
2015
PRPF31 delivery onto the retina using a nanoparticle system improves the visual acuity in a mouse model of retinal degeneration caused by A216P mutation in PRPF31 gene
B De la Cerda, FJ Diaz-Corrales, L Valdes-Sanchez, A Aramburu, ...
Investigative Ophthalmology & Visual Science 56 (7), 5412-5412, 2015
2015
Desarrollo de nanopartículas de Span como vectores en terapia génica para el tratamiento de distrofias de la retina
A Pensado López
Universidad de Santiago de Compostela (USC), 2015
2015
Span based nanoparticles as efficient non-viral vectors for in vivo PRPF31 gene delivery to treat inherited retinal dystrophy
A Pensado, FJ Diaz-Corrales, B De La Cerda, L Valdés-Sánchez, B Seijo, ...
The system can't perform the operation now. Try again later.
Articles 1–18